Aspiriant LLC’s Alibaba BABA Stock Holding History

Aspiriant LLC’s Portfolio BABA Stock Details BABA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-4,621	Closed	-$1.36M	–	203
2020 Q3	$1.36M	Buy	+4,621	New	+$1.22M	0.11%	83

Other funds holding BABA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Aspiriant LLC's BABA Position: Q4 2020 in Review

Aspiriant LLC sold out of Alibaba (BABA) in Q4 2020, closing a stake of 4,621 shares — an estimated $1.36M sold.

Aspiriant LLC first reported a position in BABA in Q3 2020 and held it in 1 quarter. The position peaked at $1.36M in Q3 2020. 1,935 funds tracked by Wall St. Rank hold BABA as of Q4 2020.

Aspiriant LLC reported no remaining Alibaba position as of Q4 2020 after selling out during the quarter.
Aspiriant LLC sold 4,621 Alibaba shares in Q4 2020, an estimated $1.36M.
Aspiriant LLC first reported a position in Alibaba in Q3 2020 and held it in 1 quarter.
Aspiriant LLC's Alibaba position peaked at $1.36M in Q3 2020.
1,935 funds tracked by Wall St. Rank held Alibaba as of Q4 2020.

Based on Aspiriant LLC's 13F filing for Q4 2020, filed 1 Feb 2021.